Real-time enrollment status for this erythropoietic protoporphyria (epp) clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 7:01 AM UTC
| NCT Number | NCT07820085 |
| Recruiting Status | Recruiting |
| Condition | Erythropoietic Protoporphyria (EPP) |
| Phase | PHASE2 |
| Target Enrollment | 225 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Portal Therapeutics, Inc. |
| Last Updated on CT.gov | September 15, 2026 (Sep 15, 2026) |
As of October 15, 2026: Clinical trial NCT07820085 is currently recruiting participants. This phase2 study for erythropoietic protoporphyria (epp) is actively seeking new participants at 2 locations across the United States. The study is sponsored by Portal Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07820085 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07820085 was last updated Sep 15, 2026 (September 15, 2026). HelloStudys verifies this status automatically.